Chemical communications (Cambridge, England)
An aryl-hydrocarbon receptor-based drug-screening strategy for hepatocellular carcinoma based on dynamic fluorescence imaging.
Yihong Sun, Junyan Li, Weiyao Sun, Weiru Yan, Chuanchen Wu, Pengfei Shi, Shusheng Zhang
Published: 202610.1039/d5cc07101a
Abstract
The development of fluorescence imaging-based drug-screening methods is crucial. We devised an AhR-specific platform AhRPH (LOD = 8.7 ng mL-1), which consists of vitamin-A functionalized liposomes targeting HSCs and encapsulating AhR-specific probes…
Preview only. Read the full abstract at the source